\u300a\u65b0\u82f1\u683c\u5170\u533b\u5b66\u6742\u5fd7\u300b<\/a>\u4e0a\u3002\u5728\u5c31\u8bca\u65f6\u7eb3\u5165\u768418\u4f8b\u60a3\u8005\u4e2d\uff0c\u5927\u591a\u6570\u80bf\u7624\u4f53\u79ef\u8f83\u5927\uff0c\u80bf\u7624\u7a81\u53d8\u8d1f\u8377\u8f83\u9ad8\uff0c94%\u4e3a\u6dcb\u5df4\u7ed3\u9633\u6027\u3002\u4e3b\u8981\u7ec8\u70b9\u662fPD-1\u6291\u5236\u5242\u8054\u5408\u6216\u4e0d\u8054\u5408CRT\u7684\u603b\u7f13\u89e3\u7387\uff08ORR\uff09\u3001PD-1\u6291\u5236\u5242\u8054\u5408\/\u4e0d\u8054\u5408CRT\u540e12\u4e2a\u6708\u7684\u6301\u7eedcCR\u6216\u624b\u672f\u60a3\u8005\u7684pCR\u3002\u524d14\u4f8b\u8fde\u7eeddMMR\u60a3\u8005\u7684\u7ed3\u679c\u60ca\u8273\uff0c\u663e\u793a\u6240\u6709\u60a3\u8005\u5747\u5728dostarlimab\u5355\u836f\u6cbb\u7597\u540e\u8fbe\u5230cCR\u3002\u91cd\u8981\u7684\u662f\uff0c\u57286.8\u4e2a\u6708\u7684\u4e2d\u4f4d\u968f\u8bbf\u671f\u5185\uff0c\u6ca1\u6709\u60a3\u8005\u9700\u8981CRT\u6216\u624b\u672f\uff0c\u672a\u89c2\u5bdf\u5230\u75be\u75c5\u590d\u53d1\u30024\u4f8b\u60a3\u8005\u5df2\u968f\u8bbf\u8fd12\u5e74\u3002\u672a\u53d1\u751f3\/4\u7ea7\u4e0d\u826f\u4e8b\u4ef6\u3002<\/p>\n\n\n\nCercek\u535a\u58eb\u603b\u7ed3\u8bf4\uff0c\u8fd9\u4e9b\u53d1\u73b0\u201c\u5f3a\u8c03\u4e86\u751f\u7269\u6807\u5fd7\u7269\u9a71\u52a8\u7597\u6cd5\u7684\u4e34\u5e8a\u5f71\u54cd\u3002\u201d\u5979\u8865\u5145\u8bf4\uff0c\u5728\u65e9\u671fdMMR\u578b\u76f4\u80a0\u764c\u60a3\u8005\u4e2d\uff0c3%-4%\u7684\u75c5\u4f8b\u6709\u671b\u514d\u4e8eCRT\u548c\u624b\u672f\u3002\u6765\u81ea\u7f8e\u56fd\u6ce2\u58eb\u987fDana-Farber\u7814\u7a76\u6240\u7684\u8ba8\u8bba\u5609\u5bbeKimmie Ng\u535a\u58eb\u53d1\u73b0\u8fd9\u4e9b\u7ed3\u8bba\u65e2\u6709\u5408\u7406\u7684\u79d1\u5b66\u4f9d\u636e\uff0c\u53c8\u5177\u6709\u4e34\u5e8a\u610f\u4e49\uff0c\u4f46\u5c1a\u4e0d\u80fd\u6539\u53d8\u5b9e\u8df5\u3002\u5979\u6307\u51fa\uff0c\u8981\u6539\u53d8\u6807\u51c6\u6cbb\u7597\uff0c\u201c\u6211\u4eec\u9700\u8981\u66f4\u5927\u7684\u6837\u672c\u91cf\u3001\u66f4\u957f\u7684\u968f\u8bbf\u65f6\u95f4\u4ee5\u53ca\u5176\u4ed6\u4e34\u5e8a\u76f8\u5173\u7ec8\u70b9\u7684\u6570\u636e\uff0c\u59823\u5e74\u65e0\u75c5\u751f\u5b58\u671f\u548c\u603b\u751f\u5b58\u671f\u4ee5\u53ca\u5668\u5b98\u4fdd\u5b58\u7387\uff0c\u540c\u65f6\u591a\u4e2d\u5fc3\u7814\u7a76\u4e5f\u81f3\u5173\u91cd\u8981\u3002\u201d\u5979\u5f3a\u8c03\u4e86\u8bc1\u5b9e\u201c\u9ad8\u4e34\u5e8a\u5b8c\u5168\u7f13\u89e3\u7387\u548c\u590d\u6742\u7684\u76f4\u80a0\u764c\u975e\u624b\u672f\u6cbb\u7597\u53ef\u4ee5\u5728\u6240\u6709\u80bf\u7624\u6cbb\u7597\u80cc\u666f\u4e2d\u590d\u5236\u201d\u7684\u91cd\u8981\u6027\u3002<\/p>\n\n\n\n
\u53c2\u8003\u6587\u732e\uff1a
Cercek A, et al. ASCO 2022: Abstract LBA5.
Cercek A, et al. N Engl J Med.<\/em> Published online June 5, 2022.<\/p>\n","protected":false},"excerpt":{"rendered":"ASCO 2022\u6700\u53d7\u5173\u6ce8\u7684\u4e13\u9898\u5206\u4eab\u4e4b\u4e00\u662fPD-1\u6291\u5236\u5242dostarlimab\u6cbb\u7597\u9519\u914d\u4fee\u590d\u7f3a\u9677\uff08dMMR\uff09II […]<\/p>\n","protected":false},"author":691,"featured_media":4188,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[41],"tags":[],"class_list":["post-4196","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-41"],"acf":[],"yoast_head":"\n
Dostarlimab\u7528\u4e8e\u5c40\u90e8\u665a\u671fdMMR\u578b\u76f4\u80a0\u764c\u5b8c\u5168\u7f13\u89e3\u6570\u636e\u4ee4\u4eba\u60ca\u8273 - ACE Oncology<\/title>\n<meta name=\"description\" content=\"Dostarlimab\u7528\u4e8e\u5c40\u90e8\u665a\u671fdMMR\u578b\u76f4\u80a0\u764c\u5b8c\u5168\u7f13\u89e3\u6570\u636e\u4ee4\u4eba\u60ca\u8273\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/aceoncology.org\/zh-hans\/asco-2022-amazing-cr-rates-with-pd1-inhibitor-in-mmrd-la-rectal-cancer\/\" \/>\n<meta property=\"og:locale\" content=\"zh_CN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Dostarlimab\u7528\u4e8e\u5c40\u90e8\u665a\u671fdMMR\u578b\u76f4\u80a0\u764c\u5b8c\u5168\u7f13\u89e3\u6570\u636e\u4ee4\u4eba\u60ca\u8273 - ACE Oncology\" \/>\n<meta property=\"og:description\" content=\"Dostarlimab\u7528\u4e8e\u5c40\u90e8\u665a\u671fdMMR\u578b\u76f4\u80a0\u764c\u5b8c\u5168\u7f13\u89e3\u6570\u636e\u4ee4\u4eba\u60ca\u8273\" \/>\n<meta property=\"og:url\" content=\"https:\/\/aceoncology.org\/zh-hans\/asco-2022-amazing-cr-rates-with-pd1-inhibitor-in-mmrd-la-rectal-cancer\/\" \/>\n<meta property=\"og:site_name\" content=\"ACE Oncology\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-28T13:52:24+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-06-28T13:54:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/06\/shutterstock_1662418102-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"562\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"j gao\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ace_oncology\" \/>\n<meta name=\"twitter:site\" content=\"@ace_oncology\" \/>\n<meta name=\"twitter:label1\" content=\"\u4f5c\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"j gao\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 \u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/asco-2022-amazing-cr-rates-with-pd1-inhibitor-in-mmrd-la-rectal-cancer\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/asco-2022-amazing-cr-rates-with-pd1-inhibitor-in-mmrd-la-rectal-cancer\/\"},\"author\":{\"name\":\"j gao\",\"@id\":\"https:\/\/aceoncology.org\/#\/schema\/person\/ccad8f084cde5a6cf908e3c506262fdf\"},\"headline\":\"Dostarlimab\u7528\u4e8e\u5c40\u90e8\u665a\u671fdMMR\u578b\u76f4\u80a0\u764c\u5b8c\u5168\u7f13\u89e3\u6570\u636e\u4ee4\u4eba\u60ca\u8273\",\"datePublished\":\"2022-06-28T13:52:24+00:00\",\"dateModified\":\"2022-06-28T13:54:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/asco-2022-amazing-cr-rates-with-pd1-inhibitor-in-mmrd-la-rectal-cancer\/\"},\"wordCount\":68,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/aceoncology.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/asco-2022-amazing-cr-rates-with-pd1-inhibitor-in-mmrd-la-rectal-cancer\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/06\/shutterstock_1662418102-1.jpg\",\"articleSection\":[\"\u4f1a\u8bae\u52a8\u6001\"],\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/aceoncology.org\/zh-hans\/asco-2022-amazing-cr-rates-with-pd1-inhibitor-in-mmrd-la-rectal-cancer\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/asco-2022-amazing-cr-rates-with-pd1-inhibitor-in-mmrd-la-rectal-cancer\/\",\"url\":\"https:\/\/aceoncology.org\/zh-hans\/asco-2022-amazing-cr-rates-with-pd1-inhibitor-in-mmrd-la-rectal-cancer\/\",\"name\":\"Dostarlimab\u7528\u4e8e\u5c40\u90e8\u665a\u671fdMMR\u578b\u76f4\u80a0\u764c\u5b8c\u5168\u7f13\u89e3\u6570\u636e\u4ee4\u4eba\u60ca\u8273 - ACE Oncology\",\"isPartOf\":{\"@id\":\"https:\/\/aceoncology.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/asco-2022-amazing-cr-rates-with-pd1-inhibitor-in-mmrd-la-rectal-cancer\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/asco-2022-amazing-cr-rates-with-pd1-inhibitor-in-mmrd-la-rectal-cancer\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/06\/shutterstock_1662418102-1.jpg\",\"datePublished\":\"2022-06-28T13:52:24+00:00\",\"dateModified\":\"2022-06-28T13:54:52+00:00\",\"description\":\"Dostarlimab\u7528\u4e8e\u5c40\u90e8\u665a\u671fdMMR\u578b\u76f4\u80a0\u764c\u5b8c\u5168\u7f13\u89e3\u6570\u636e\u4ee4\u4eba\u60ca\u8273\",\"breadcrumb\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/asco-2022-amazing-cr-rates-with-pd1-inhibitor-in-mmrd-la-rectal-cancer\/#breadcrumb\"},\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/aceoncology.org\/zh-hans\/asco-2022-amazing-cr-rates-with-pd1-inhibitor-in-mmrd-la-rectal-cancer\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/asco-2022-amazing-cr-rates-with-pd1-inhibitor-in-mmrd-la-rectal-cancer\/#primaryimage\",\"url\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/06\/shutterstock_1662418102-1.jpg\",\"contentUrl\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/06\/shutterstock_1662418102-1.jpg\",\"width\":1000,\"height\":562},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/asco-2022-amazing-cr-rates-with-pd1-inhibitor-in-mmrd-la-rectal-cancer\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"ACE Oncology\",\"item\":\"https:\/\/aceoncology.org\/zh-hans\/chinese-home\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Dostarlimab\u7528\u4e8e\u5c40\u90e8\u665a\u671fdMMR\u578b\u76f4\u80a0\u764c\u5b8c\u5168\u7f13\u89e3\u6570\u636e\u4ee4\u4eba\u60ca\u8273\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/aceoncology.org\/#website\",\"url\":\"https:\/\/aceoncology.org\/\",\"name\":\"ACE Oncology\",\"description\":\"ACE Oncology is a global independent medical education resource that provides evidence-based, high-quality educational solutions for clinicians that treat patients with cancer.\",\"publisher\":{\"@id\":\"https:\/\/aceoncology.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/aceoncology.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/aceoncology.org\/#organization\",\"name\":\"ACE Oncology\",\"url\":\"https:\/\/aceoncology.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\/\/aceoncology.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/05\/Logo.png\",\"contentUrl\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/05\/Logo.png\",\"width\":156,\"height\":83,\"caption\":\"ACE Oncology\"},\"image\":{\"@id\":\"https:\/\/aceoncology.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/ace_oncology\",\"https:\/\/www.linkedin.com\/company\/aceoncology\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/aceoncology.org\/#\/schema\/person\/ccad8f084cde5a6cf908e3c506262fdf\",\"name\":\"j gao\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\/\/aceoncology.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/afe10fca3d4cc45c0cd0b8bf85070e61056e2c5e5c887f814736bbe9e6243d1e?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/afe10fca3d4cc45c0cd0b8bf85070e61056e2c5e5c887f814736bbe9e6243d1e?s=96&d=mm&r=g\",\"caption\":\"j gao\"},\"url\":\"https:\/\/aceoncology.org\/zh-hans\/author\/jgao\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Dostarlimab\u7528\u4e8e\u5c40\u90e8\u665a\u671fdMMR\u578b\u76f4\u80a0\u764c\u5b8c\u5168\u7f13\u89e3\u6570\u636e\u4ee4\u4eba\u60ca\u8273 - ACE Oncology","description":"Dostarlimab\u7528\u4e8e\u5c40\u90e8\u665a\u671fdMMR\u578b\u76f4\u80a0\u764c\u5b8c\u5168\u7f13\u89e3\u6570\u636e\u4ee4\u4eba\u60ca\u8273","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/aceoncology.org\/zh-hans\/asco-2022-amazing-cr-rates-with-pd1-inhibitor-in-mmrd-la-rectal-cancer\/","og_locale":"zh_CN","og_type":"article","og_title":"Dostarlimab\u7528\u4e8e\u5c40\u90e8\u665a\u671fdMMR\u578b\u76f4\u80a0\u764c\u5b8c\u5168\u7f13\u89e3\u6570\u636e\u4ee4\u4eba\u60ca\u8273 - ACE Oncology","og_description":"Dostarlimab\u7528\u4e8e\u5c40\u90e8\u665a\u671fdMMR\u578b\u76f4\u80a0\u764c\u5b8c\u5168\u7f13\u89e3\u6570\u636e\u4ee4\u4eba\u60ca\u8273","og_url":"https:\/\/aceoncology.org\/zh-hans\/asco-2022-amazing-cr-rates-with-pd1-inhibitor-in-mmrd-la-rectal-cancer\/","og_site_name":"ACE Oncology","article_published_time":"2022-06-28T13:52:24+00:00","article_modified_time":"2022-06-28T13:54:52+00:00","og_image":[{"width":1000,"height":562,"url":"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/06\/shutterstock_1662418102-1.jpg","type":"image\/jpeg"}],"author":"j gao","twitter_card":"summary_large_image","twitter_creator":"@ace_oncology","twitter_site":"@ace_oncology","twitter_misc":{"\u4f5c\u8005":"j gao","\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4":"1 \u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/aceoncology.org\/zh-hans\/asco-2022-amazing-cr-rates-with-pd1-inhibitor-in-mmrd-la-rectal-cancer\/#article","isPartOf":{"@id":"https:\/\/aceoncology.org\/zh-hans\/asco-2022-amazing-cr-rates-with-pd1-inhibitor-in-mmrd-la-rectal-cancer\/"},"author":{"name":"j gao","@id":"https:\/\/aceoncology.org\/#\/schema\/person\/ccad8f084cde5a6cf908e3c506262fdf"},"headline":"Dostarlimab\u7528\u4e8e\u5c40\u90e8\u665a\u671fdMMR\u578b\u76f4\u80a0\u764c\u5b8c\u5168\u7f13\u89e3\u6570\u636e\u4ee4\u4eba\u60ca\u8273","datePublished":"2022-06-28T13:52:24+00:00","dateModified":"2022-06-28T13:54:52+00:00","mainEntityOfPage":{"@id":"https:\/\/aceoncology.org\/zh-hans\/asco-2022-amazing-cr-rates-with-pd1-inhibitor-in-mmrd-la-rectal-cancer\/"},"wordCount":68,"commentCount":0,"publisher":{"@id":"https:\/\/aceoncology.org\/#organization"},"image":{"@id":"https:\/\/aceoncology.org\/zh-hans\/asco-2022-amazing-cr-rates-with-pd1-inhibitor-in-mmrd-la-rectal-cancer\/#primaryimage"},"thumbnailUrl":"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/06\/shutterstock_1662418102-1.jpg","articleSection":["\u4f1a\u8bae\u52a8\u6001"],"inLanguage":"zh-Hans","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/aceoncology.org\/zh-hans\/asco-2022-amazing-cr-rates-with-pd1-inhibitor-in-mmrd-la-rectal-cancer\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/aceoncology.org\/zh-hans\/asco-2022-amazing-cr-rates-with-pd1-inhibitor-in-mmrd-la-rectal-cancer\/","url":"https:\/\/aceoncology.org\/zh-hans\/asco-2022-amazing-cr-rates-with-pd1-inhibitor-in-mmrd-la-rectal-cancer\/","name":"Dostarlimab\u7528\u4e8e\u5c40\u90e8\u665a\u671fdMMR\u578b\u76f4\u80a0\u764c\u5b8c\u5168\u7f13\u89e3\u6570\u636e\u4ee4\u4eba\u60ca\u8273 - ACE Oncology","isPartOf":{"@id":"https:\/\/aceoncology.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/aceoncology.org\/zh-hans\/asco-2022-amazing-cr-rates-with-pd1-inhibitor-in-mmrd-la-rectal-cancer\/#primaryimage"},"image":{"@id":"https:\/\/aceoncology.org\/zh-hans\/asco-2022-amazing-cr-rates-with-pd1-inhibitor-in-mmrd-la-rectal-cancer\/#primaryimage"},"thumbnailUrl":"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/06\/shutterstock_1662418102-1.jpg","datePublished":"2022-06-28T13:52:24+00:00","dateModified":"2022-06-28T13:54:52+00:00","description":"Dostarlimab\u7528\u4e8e\u5c40\u90e8\u665a\u671fdMMR\u578b\u76f4\u80a0\u764c\u5b8c\u5168\u7f13\u89e3\u6570\u636e\u4ee4\u4eba\u60ca\u8273","breadcrumb":{"@id":"https:\/\/aceoncology.org\/zh-hans\/asco-2022-amazing-cr-rates-with-pd1-inhibitor-in-mmrd-la-rectal-cancer\/#breadcrumb"},"inLanguage":"zh-Hans","potentialAction":[{"@type":"ReadAction","target":["https:\/\/aceoncology.org\/zh-hans\/asco-2022-amazing-cr-rates-with-pd1-inhibitor-in-mmrd-la-rectal-cancer\/"]}]},{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/aceoncology.org\/zh-hans\/asco-2022-amazing-cr-rates-with-pd1-inhibitor-in-mmrd-la-rectal-cancer\/#primaryimage","url":"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/06\/shutterstock_1662418102-1.jpg","contentUrl":"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/06\/shutterstock_1662418102-1.jpg","width":1000,"height":562},{"@type":"BreadcrumbList","@id":"https:\/\/aceoncology.org\/zh-hans\/asco-2022-amazing-cr-rates-with-pd1-inhibitor-in-mmrd-la-rectal-cancer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"ACE Oncology","item":"https:\/\/aceoncology.org\/zh-hans\/chinese-home\/"},{"@type":"ListItem","position":2,"name":"Dostarlimab\u7528\u4e8e\u5c40\u90e8\u665a\u671fdMMR\u578b\u76f4\u80a0\u764c\u5b8c\u5168\u7f13\u89e3\u6570\u636e\u4ee4\u4eba\u60ca\u8273"}]},{"@type":"WebSite","@id":"https:\/\/aceoncology.org\/#website","url":"https:\/\/aceoncology.org\/","name":"ACE Oncology","description":"ACE Oncology is a global independent medical education resource that provides evidence-based, high-quality educational solutions for clinicians that treat patients with cancer.","publisher":{"@id":"https:\/\/aceoncology.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/aceoncology.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-Hans"},{"@type":"Organization","@id":"https:\/\/aceoncology.org\/#organization","name":"ACE Oncology","url":"https:\/\/aceoncology.org\/","logo":{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/aceoncology.org\/#\/schema\/logo\/image\/","url":"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/05\/Logo.png","contentUrl":"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/05\/Logo.png","width":156,"height":83,"caption":"ACE Oncology"},"image":{"@id":"https:\/\/aceoncology.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/ace_oncology","https:\/\/www.linkedin.com\/company\/aceoncology"]},{"@type":"Person","@id":"https:\/\/aceoncology.org\/#\/schema\/person\/ccad8f084cde5a6cf908e3c506262fdf","name":"j gao","image":{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/aceoncology.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/afe10fca3d4cc45c0cd0b8bf85070e61056e2c5e5c887f814736bbe9e6243d1e?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/afe10fca3d4cc45c0cd0b8bf85070e61056e2c5e5c887f814736bbe9e6243d1e?s=96&d=mm&r=g","caption":"j gao"},"url":"https:\/\/aceoncology.org\/zh-hans\/author\/jgao\/"}]}},"_links":{"self":[{"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/posts\/4196","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/users\/691"}],"replies":[{"embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/comments?post=4196"}],"version-history":[{"count":2,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/posts\/4196\/revisions"}],"predecessor-version":[{"id":4198,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/posts\/4196\/revisions\/4198"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/media\/4188"}],"wp:attachment":[{"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/media?parent=4196"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/categories?post=4196"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/tags?post=4196"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}